The LDN 2017 Conference

We would like to thank all the speakers for taking part in the conference, and for their amazing presentations. 

Presentations on LDN pharmacology; the opioid system; and LDN’s role in treating autoimmune disorders eg Ehlers-Danlos Syndrome (EDS), eosinophilic esophagitis, myasthenia gravis, glycogen storage disorder (GSD VII), pemphigus vulgaris, Crackly Brain or Middle Ear Myoclonus (MEM), multiple sclerosis (MS), Parkinson’s, Lyme disease, Type 1 diabetes (T1DM), psoriasis and psoriatic arthritis, Crohn’s, vitiligo, cancer and cancer therapy, pain, CFS/ME, fibromyalgia, lupus, irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO); gut dysbiosis, nutrition, and gut healing; Vitamin D3, thyroid disorders, Hashimoto’s HIV/AIDS, hormone balance, autism, traumatic brain injury (TBI), post-traumatic stress disorders, pets, gastroparesis, rheumatoid arthritis, alcohol use disorder, phobias, children, complex regional pain syndrome (CPRS), celiac disease, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), ulcerative colitis, lichen, mental health and substance abuse disorders.

Using an Old Drug to Trick the Immune System into Healing Itself - Stephen Dickson, BSC (hons), MRPharmS

Treating the Zebras in Primary Care - Jill Cottel, MD

The Role of the Opioid System in Immune-Mediated Disease - Anthony Turel, MD

Multiple Sclerosis: Result-Based Immune Therapies Beyond Those Normally Offered - Paul S. Anderson, NMD

Q&A - The Q&A Panel

Modern Laboratory Tests for Diagnosing Lyme disease - Armin Schwarzbach, MD, PhD

Immune Dysfunction and Chronic Lyme Disease - Kent Holtorf, MD

A Novel Approach to Type 1 Diabetes Mellitus - Paul Battle, PA-C

Pediatric and Geriatric Dosing for LDN - Deanna Windham, DO

Psoriasis: A Novel Approach to Treatment - Deanna Windham, DO

Vitamin D and Autoimmune Disease: A Systematic Review of the Literature - Jill Cottel, MD

Q&A - The Q&A Panel

Understanding and Managing Neuropathic and Inflammatory Pain - Leonard Weinstock, MD

Beyond Tired: CFS/ME or Not? - Sarah Zielsdorf, MD, MS

The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 - Jarred Younger, PhD

Turning Down the Volume on Fibromyalgia Pain - Ginevra Liptan, MD

Q&A - The Q&A Panel

Irritable Bowel Syndrome: The Roles of Small Intestinal Bacterial Overgrowth (SIBO) and Mucosal/Systemic Inflammation - Leonard Weinstock, MD

Crohn's Disease: Latest Integrative Immunologic Therapies - Paul S. Anderson, NMD

An introduction to Fire in the Hole--Intestinal Permeability, The Development of Autoimmune Disease, and a Comprehensive Approach to Healing the Gut - Thomas O’Bryan, DC, CCN, DACBN

What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets - Jill Brook, MA

The Role of Non-Cytotoxic Drugs in the Management of Cancer - Professor Angus Dalgleish

Broad spectrum, Gentler Anti-Neoplastics: Breaking the cycle of toxic therapy - Akbar Khan, MD

Q&A - The Q&A Panel

Thyroid Autoimmunity: Causal Relationships & Novel Therapeutics - John A. Robinson, NMD

Navigating the Narrative with your Health Care Team - Nasha Winters, ND

The low down on low dose naltrexone - Nasha Winters, ND

Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice - Brian Udell, MD

Opioid Antagonists and Traumatic Brain Injury - Ulrich Lanius, PhD and Galyn Forster, MS, LPC

A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorders - Wiebke Pape, MD

A Guide to Testing Steroid and Peptide Hormones in Different Body Fluids - David Zava, PhD

LDN and Pets - Mark Mandel, PharmD

Q&A - The Q&A Panel

Gastroparesis - Beth Livengood, ND - Case Study - LDN 2017 Conference

Rheumatoid Arthritis - Beth Livengood, ND - Case Study - LDN 2017 Conference

Michael Ludwig, MS, PhD - Multiple Sclerosis

Paul S. Anderson, NMD - Cancer Presentation

Paul S. Anderson, NMD - Case Studies

Gaylyn Forster, MS, LPC - LDN for Mental Health Including Dosing

Sara J. Zielsdorf, MD, MS - Case Study - Hashimoto's

Darin Ingels, ND - Case Studies - Lyme Disease

Tom O'Bryan, DC, CCN, DACBN - Gut Healing

Galyn Forester, MS, LPC - Veterans with PTSD - 3 Case Studies

Armin Schwarzbach, MD, PhD - Lyme Borreliosis

Ginevra Liptan, MD - Fibromyalgia

Debbie Rice, ND - LDN regulating immune and inflammatory response

Jill Cottel, MD - Alcohol Use Disorder

Wiebke Pape, MD - Dissociative symptoms in trauma-related disorders

Galyn Forster, MS, LPC - An Introduction to Phobia of Shared Positive Affect

Darin Ingels, ND, BCIP LDN and Children

Leonard Weinstock, MD - Celiac Disease

Leonard Weinstock, MD - Inflammatory Bowel Disease

Leonard Weinstock, MD - Postural Orthostatic Tachycardia and Mast Cell Activation Syndromes

Jill Brook, MA - Dietary Strategies to Fight Autoimmunity

Paul Battle, PA-C - Possible Mechanisms of Naltrexone's Effects on Cancer

Laurie Marzell, ND, NCMP - LDN Cases #1-6

Brian Udell, MD - Low Dose Naltrexone & Autism Spectrum Disorder

Ulrich Lanius, PhD - Traumatic Stress and Dissociative Symptoms

Cory Tichauer, ND - LDN in a Complex Case of Lyme Disease With Co-Morbid Lupus, Asthma and Fibromyalgia

Deanna Windham, DO - Bipolar Presentation The Conundrum of Bipolar Disorder

Deanna Windham, DO - Lupus: A Misunderstood Disease

Pradeep Chopra, MD - Chronic Pain And LDN

John A. Robinson, NMD - Thyroid Disease: Optimizing Metabolism Through Comprehensive Hormonal Treatment

Mark Shukhman, MD - Low Dose Naltrexone (LDN) for Treatment of Postcoital Dysphoria

Samyadev Datta, MD, FRCA(Eng) - Use of Low Dose Naltrexone in Pain Management